Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

J & J Acquires Merck’s Stake in Joint Venture

By Pharmaceutical Processing | September 28, 2011

Drugmaker Merck & Co. has sold its interest in a joint venture that makes and sells over-the-counter drugs to Johnson & Johnson for $175 million, the companies said Wednesday.

 

The 22-year-old joint venture, Johnson & Johnson-Merck Consumer Pharmaceuticals Co., does business in the U.S. and Canada. Merck said it is selling its 50 percent stake so it can focus on the consumer products business of Schering-Plough, which Merck acquired in November 2009. It said the deal also gives it “greater freedom to cooperate in the OTC consumer sector.”

 

The deal gives Johnson & Johnson the right to market Pepcid, Mylanta, Mylicon and other brands. Merck said the deal does not affect its rights to the Pepcid brand in countries other than the U.S. and Canada.

 

Johnson & Johnson said it will rename the business McNeil Consumer Pharmaceuticals Co. and said the acquisition will allow its McNeil division to expand its digestive health business.

 

Merck is based in Whitehouse Station, N.J. Johnson & Johnson is headquartered in New Brunswick, N.J.

 

Merck shares lost 20 cents to $31.94 Wednesday and picked up 26 cents to $32.20 in aftermarket trading. Shares of Johnson & Johnson fell 57 cents to $63.25 during the day session, and gained 35 cents to $63.60 aftermarket.

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE